This inventor holds 2 USPTO granted patents. Top assignee: Ahlstrom Filtration, Inc.. Active years: 1993-2024.
Company Filing History:
Years Active: 1993-2024
Title: Innovations by Mark D. Loewen
Introduction
Mark D. Loewen is an accomplished inventor based in Hershey, PA (US). He has made significant contributions to the field of technology with a focus on antimicrobial surfaces and blood separation methods. With a total of 2 patents, his work reflects a commitment to improving health and safety through innovative solutions.
Latest Patents
One of Loewen's latest patents is for a battery-activated metal ionic antimicrobial surface. This invention is designed for external use in indoor environments and features a unique surface structure with conductive strips and insulative spacings. The power pod structure houses a battery and a power control circuit, ensuring a consistent reduction in microbial contaminants. The antimicrobial surface is capable of achieving a continuous reduction of at least 99% in microbial contaminants over a replaceable period of at least a month.
Another notable patent is for a blood separation medium and method for separating plasma from whole blood. This single-layer medium is made from a composite of glass microfibers, cellulose fibers, and synthetic textile fibers. It boasts enhanced tensile strength and lower absorptive capacity compared to traditional materials. The design allows for efficient separation of erythrocytes from whole blood, contributing to advancements in medical technology.
Career Highlights
Mark D. Loewen is currently employed at Ahlstrom Filtration, Inc., where he continues to innovate and develop new technologies. His work has garnered attention for its practical applications in healthcare and environmental safety.
Collaborations
Loewen collaborates with talented individuals such as John S. Baumgardner and Christopher M. Wharton. Their combined expertise fosters a creative environment that drives innovation forward.
Conclusion
Mark D. Loewen's contributions to the fields of antimicrobial technology and blood separation demonstrate his dedication to improving health outcomes. His innovative patents reflect a forward-thinking approach that addresses critical challenges in modern society.